R079 (compound 17), a selective and orally active Nrf2 activator, enhances Nrf2 translocation activity (EC 50 = 32.41 µM) and can neutralize excess levels of reactive oxygen species by activating Nrf2. Additionally, R079 possesses anti-inflammatory properties and has applications in multiple sclerosis research [1].
Molecular Weight:
265.29
CAS Number:
[2115659-62-4]
Formula:
C11H11N3O3S
Target:
Nrf2
T87293
* VAT and and shipping costs not included. Errors and price changes excepted
